Treatment of Adults With Newly Diagnosed Glioblastoma With Partial Brain Radiation Therapy Plus Temozolomide and Chloroquine Followed by Tumor Treating Fields Plus Temozolomide and Chloroquine -- A Pilot Study
Latest Information Update: 28 Mar 2024
At a glance
- Drugs Chloroquine (Primary) ; Temozolomide (Primary)
- Indications Glioblastoma; Glioma; Gliosarcoma
- Focus Adverse reactions
- 25 Mar 2024 Planned End Date changed from 27 Apr 2025 to 27 Apr 2026.
- 25 Mar 2024 Planned primary completion date changed from 27 Apr 2024 to 27 Apr 2025.
- 25 Mar 2024 Status changed from recruiting to active, no longer recruiting.